MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Myriad Genetics ROA Ratio 2011-2025 | MYGN
Annual ROA Ratio Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.39 | -22.97 | -9.34 | -2.06 | -3.78 | 0.29 | 11.17 | 1.78 | 14.23 | 10.47 | 21.39 | 18.3 | 16.24 | 16.49 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.39 | -22.97 | 4.27 |
Quarterly ROA Ratio Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -56.65 | -56.27 | -7.77 | -13.1 | -16.39 | -22.79 | -19.79 | -22.69 | -20.25 | -12.1 | -6.16 | -4.32 | 2.05 | 1.7 | -1.46 | -4.13 | -7.04 | -10.6 | -8.72 | -6.57 | -6.02 | -2.65 | -2.9 | -2.2 | -1.52 | -0.76 | 0.49 | 2.84 | 9.09 | 11.53 | 18.21 | 16.17 | 9.7 | 7.72 | 0.96 | 4.73 | 8.64 | 11.92 | 15.53 | 14.35 | 12.47 | 11.44 | 9.9 | 13.49 | 18.61 | 21.96 | 26.92 | 25.14 | 22.33 | 21.14 | 18.6 | 18.0 | 17.82 | 17.38 | 17.12 | 4.1 | 4.63 | 4.11 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 26.92 | -56.65 | 1.86 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 19.37 | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 21.18 | - | $ 228 M |  China |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.24 | - | $ 7.04 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.4 | - | $ 1.09 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 230.32 | - | $ 168 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.04 | - | $ 285 M | Israel |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.52 | - | $ 1.93 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.57 | - | $ 18.8 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
8.64 | $ 67.57 | - | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.72 | - | $ 808 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.48 | - | $ 1.05 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 102.25 | - | $ 4.03 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.2 | - | $ 102 K | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 5.08 | - | $ 2.73 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 7.13 | - | $ 1.55 B | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 226.92 | - | $ 41.1 B | USA |
 |
National Research Corporation
NRC
|
25.3 | $ 18.66 | - | $ 458 M | USA |
 |
Guardant Health
GH
|
-29.37 | $ 102.98 | - | $ 12.6 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 8.14 | - | $ 482 M | USA |
 |
Quidel Corporation
QDEL
|
43.3 | $ 29.3 | - | $ 1.23 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | $ 45.37 | - | $ 10.1 B |  Niderland |
 |
RadNet
RDNT
|
0.08 | $ 73.15 | - | $ 5.34 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 134.95 | - | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 203.66 | - | $ 10.5 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 175.94 | - | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 6.82 | - | $ 884 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 253.89 | - | $ 21.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.51 | $ 580.74 | - | $ 222 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.84 | - | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 688.48 | - | $ 56.8 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 66.71 | - | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 420.1 | - | $ 30.1 B |  Schweiz |